Key result
Diabetes and diabetic nephropathy severely affect hemostasis by increasing coagulation factors like fibrinogen and VWF, and altering ADAMTS13, thereby increasing the risk of cardiovascular disease.
Why the study?
Vascular complications cause morbidity and mortality in diabetes, with diabetic nephropathy serving as a major life-threatening problem and leading cause of end-stage renal disease.
Diabetes and diabetic nephropathy induce a prothrombotic state characterized by elevated fibrinogen and VWF and altered ADAMTS13, increasing the risk of vascular complications.
Supports vigilant thrombotic risk assessment in diabetic nephropathy; leaves open whether modulating hemostasis improves outcomes.
Vascular complications lead to morbidity and mortality in patients with diabetes. Diabetic nephropathy (DN) is one of the main life-threatening problems for these patients, as it is the main cause of end-stage renal disease. This study aimed to measure the clinical effects of diabetes in patients with diabetes and in patients with diabetic nephropathy. Improved hypoglycemic control in patients with diabetes could impressively reduce platelet hyperreactivity, and oxidative stress alters the levels of many coagulation and thrombosis factors, resulting in an abnormal hemostasis and impaired levels of numerous serum markers. Most studies have revealed that coagulation factor levels are high in patients with diabetes and nephrodiabetes. Serum inflammatory factors, and coagulation and endothelial functions are good predictors of diabetic nephropathy. This literature review was conducted with access to scholarly databases and Google Scholar through Qassim University, and it analyzes studies from early 2010 until November 2020. Many studies have inferred that diabetes severely affects hemostasis and increases the risk of cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Ashwag Saleh Alsharidah (2022) conducted a review in Diabetes mellitus and diabetic nephropathy. Diabetes mellitus and diabetic nephropathy vs. Individuals without diabetes was evaluated on Levels of coagulation and thrombosis factors (fibrinogen, VWF, and ADAMTS13). Diabetes and diabetic nephropathy severely affect hemostasis by increasing coagulation factors like fibrinogen and VWF, and altering ADAMTS13, thereby increasing the risk of cardiovascular disease.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: